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ABSTRACT 
Purpose: The pathophysiology of non-arteritic AION (N-AION) is not completely 
understood. Studies of the retinal vasculature phenotype in patients with N-AION 
could help us to understand vascular abnormalities associated with the disease.  
Design: Retrospective case series with matched controls. 
Methods:  
Study population: 57 patients with N-AION and 57 controls matched to N-AION 
patients for sex, age, systemic hypertension, diabetes and obstructive sleep apnea 
syndrome, between September 2007 and July 2017. 
Main outcomes measures: All patients and control subjects underwent a complete 
ocular examination and 45-degree funduscopic color photographs. The widths of the 
six largest arteries in zone B (between 0.5 and 1 optic disc diameter from the optic 
disc), summarized by the central retinal artery equivalent (CRAE), the widths of the 
six largest veins in zone B, summarized by the central retinal vein equivalent 
(CRVE), the arteriole-tovenule ratio (AVR), tortuosity and fractal dimension (FD) 
were measured on the two groups using VAMPIRE (Vessel Assessment and 
Measurement Platform for Images of the Retina), a software tool for efficient semi-
automatic quantification of the retinal vasculature morphology in fundus camera 
images. Univariate analysis using the Student t-test and MacNemar Chi-squared 
test for paired sample and Generalized Estimated Equations for modeling the 
VAMPIRE parameters as dependent variables were used.  
Results: CRVE and FD (D0a) were significantly higher in the N-AION group when 
compared with the control group, whereas the AVR and vascular tortuosity were 
significantly lower. In comparison with controls, acute N-AION yielded increased 
CRAE value (174 ±33 vs. 160 ±13 μm) while resolution N-AION yielded decreased 
CRAE value (152 ±12 vs. 156 ±33 μm). Acute N-AION yielded increased CRVE 
value (244 ±35 vs. 210 ±21 μm) while resolution N-AION yielded unchanged CRVE 
value. We found no difference between groups for age, refraction, optic disc 
diameter, CRAE, and FD. 
Conclusions: Retinal vascular parameters were different in our sample between N-
AION and control patients, especially at the acute stage of the disease. Our results 
suggest a normalization of the same parameters at the resolution stage.  
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Re: AJO-18-1019, "Retinal Vessel Phenotype in Patients 
with Non-Arteritic Anterior Ischemic Optic Neuropathy." 
 
 
Grenoble, 04/03/2019 
 
Dear Editor, 
 
We appreciate your decision to consider a second revision 
of our manuscript entitled  
" Retinal Vessel Phenotype in Patients with Non-Arteritic 
Anterior Ischemic Optic Neuropathy" which was submitted 
to the American Journal of Ophthalmology. 
 
We are also grateful to the reviewers for their thorough 
examination of our manuscript and for the practical 
presentation of their comments. Please find below item-by-
item responses to the reviewers’ comments, which are 
included verbatim for their convenience. All page and 
paragraph numbers refer to the revised manuscript. 
 
All authors have seen and approved the new manuscript. 
The manuscript has not been published and is not being 
considered for publication elsewhere. 
 
We hope that the new version of our paper, which has 
been rewritten taking the reviewers' comments into 
account, is deemed worthy of publication. 
 
 
 
Sincerely yours, 
 
Prof. Christophe CHIQUET, MD, PhD  
 
 
 
 
 
    
 
 
 
  
 
 
Cover Letter
  
1. The authors have appropriately acknowledged in the results that the 
"significant" differences in the D0a values were driven by changes in 
the control subgroups and likely due to confounding or random variation. 
[The specific data points are: D0a NAION Acute 1.55 (IQR 1.51-1.59), 
Resolution 1.55 (1.54-1.59) versus Controls Acute 1.54 (1.48-1.5 and 
Resolution 1.50 (1.46-1.56)] The statistical association is artifactual 
and weak enough that likely would not survive correction for multiple 
comparisons. Despite the acknowledgment in the results, changes in D0a 
are still claimed in the abstract and the discussion as a major finding 
of the manuscript. This is not accurate and cannot be allowed. Moreover, 
the numbers reported in the abstract are not consistent with those 
reported in Table2. Any reference to change in FD/D0a needs to be 
removed from the abstract. In the discussion, the reference to D0a needs 
to be removed from the first paragraph and the entire 5th paragraph 
needs to be removed. (The first sentence of this paragraph, "We found 
that fractal dimension (D0a) increased at the resolution stage", is 
completely false; D0a was 1.55 in the acute phase and 1.55 in the 
resolution phase.) The only statement in the discussion about FD that I 
believe is worthy of retaining is at the end of the 7th paragraph where 
you state that "the stability and repeatability of FD measures is the 
object of ongoing analysis." Any additional conclusions from this 
measure are problematic. 
 
 
 
- Data have been corrected accordingly in the abstract  
- Results concerning fractal dimension are discussed, the 5th paragraph of 
the discussion has been changed accordingly  
 
 
 
 
2. The first review requested that the figure include representative images 
illustrating the morphological differences between vessels in a control 
fundus and a NAION fundus. This has not been done.  
 
Probably we did not understand exactly what the reviewer asked for. Therefore we 
added figures with an illustration of fundus images for the measurement of CRAE and 
CRVE in zone B and FD in zone C, in a control subjects and in a NAION patients. 
Indeed it is impossible to illustrate an higher CRVE and lower AVR and vascular 
tortuosity form one image since these measurements are slight and not necessarily 
visible on one fundus image.  
 
 
 
 
3. The demographics are still not complete. The first review specifically 
requested that demographics be reported individually for both control 
subgroups. This is important because the D0a measure suggests the 
presence of a confounder between these sub-groups.  
Table 1 reports age, gender, and main risk factor for NAION such as OSA, diabetes 
and systemic hypertension. As we stated in the first review, we did not report 
smoking rates and hypercholesterolemia for our patients and controls. Furthermore, 
We did not evaluate the body mass index, drugs, or other ocular data such as the 
size of the optic nerve, intraocular pressure, axial length. This is now discussed 
as a possible limitation.   
 
 
4.      Please change N-AION to NAION and A-AION to AAION in all instances. 
This has been changed accordingly. 
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INTRODUCTION 
Anterior ischemic optic neuropathy (AION) is the most common acute optic neuropathy in 
people over the age of 50, with an incidence of 2–10 per 100,000 people per year.(1) AION 
results from ischemic events within the optic nerve supplied by the short posterior ciliary 
arteries. Such events may be related to systemic vasculitis affecting large and medium-
caliber vessels in giant cell arteritis (arteritic AION); or to blood flow disturbances in non-
arteritic ischemic optic neuropathy (NAION). The main risk factors of NAION are crowded 
disc,(1)  systemic hypertension, diabetes mellitus, and obstructive sleep apnea (OSA).(1–3) 
The retinal vasculature provides a unique window to assess noninvasively and directly 
vasculature segments in vivo, and reflects the efficiency of the circulation and the distribu-
tion of shear stress. A previous pilot study grading retinal vasoconstriction as absent, mild, 
moderate or severe (4) reported proximal retinal arterial constriction in 68% of patients with 
NAION. Retinal vascular impairment may be also due to comorbidities associated with 
NAION or to the vascular dysfunction of the posterior ciliary arteries. Given that the patho-
physiology of NAION is not clearly understood, investigations of the ocular vascular beds 
may help us to formulate new hypothesis.  
Over the last decade, several population-based studies have reported associations of 
summative measurements of the width of retinal vessels (e.g. AVR), as well as tortuosity 
and fractal dimension (FD), with a wide range of subclinical (e.g. atherosclerosis, inflam-
mation and endothelial dysfunction) and clinical cardiovascular diseases (hypertension, 
diabetes mellitus, stroke, kidney and heart diseases).(5,6) 
The objective of this study was to characterize the morphology of retinal vessels using 
well-established retinal vascular parameters, namely the central retinal artery equivalent 
(CRAE), central retinal vein equivalent (CRVE), AVR, tortuosity and FD,  in eyes with 
NAION compared to controls matched for major risk factors associated with NAION such 
as age, diabetes, systemic hypertension, and OSA. We used the VAMPIRE (Vessel As-
sessment and Measurement Platform for Images of the REtina, Universities of Edinburgh 
and Dundee, UK) software to collect quantitative measurements of the vascular morphol-
ogy.(7) 
 
Material and methods 
Participants 
This study, conducted at the Grenoble-Alpes University Hospital, retrospectively included 
patients imaged between September 2007 and July 2017. It was conducted in accordance 
with the ethical principles of the Declaration of Helsinki on medical research in patients 
and approved by the regional ethics committee (IRB #5891).  
 
NAION group 
The group of patients suffering from NAION included 57 patients aged 18 years or over 
with the following inclusion criteria: (1) a history of sudden (less than 14 days between the 
first symptoms and the examination) painless loss of vision, (2) optic disc edema at the 
time of visual loss, (3) visual field defects consistent with optic-disc pathology, (4) absence 
of another neurologic or ocular disorder that may be responsible for optic disc edema and 
visual impairment, and (5) exclusion of arteritic anterior ischemic optic neuropathy 
(AAION, Horton disease). The resolution phase of AION was defined by the 
disappearance of the optic nerve edema.(8) Exclusion criteria were patients with ametropia 
> 5 diopters (spherical equivalent) or with any other ocular disease. 
Diurnal hypertension was defined as daytime systolic blood pressure of at least 135 mm 
Hg, or daytime diastolic blood pressure of at least 85 mm Hg. 
 
Control group 
57 controls were included in the same clinic and matched to NAION patients for sex, age 
(10-year interval), systemic hypertension, diabetes and OSA. Exclusion criteria were pa-
tients with ametropia > 5 diopters (spherical equivalent) or with any ocular disease. Medi-
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cal history, particularly cardiovascular risk factors, high-blood pressure, diabetes, 
dyslipidemia and smoking, was collected on the basis of self-declaration. Epworth and 
NoSAS scores (9,10) were obtained for all controls without previously known OSA syn-
drome, in order to exclude control subjects with an Epworth score > 8 and / or a NoSAS 
score> 8. 
 
Clinical data and imaging protocol 
All patients and control subjects underwent a complete ocular examination including visual 
acuity (VA) and measurement of intraocular pressure (IOP, non-contact tonometry, 
TONOREF II, Nidek™, Gamagori, Japan). Anterior segment slit lamp examination and 
fundus examination were performed to rule out ocular diseases.  
45-degree funduscopic color photographs were acquired (one per eye), centered on the 
optic nerve and the macula, using a non-mydriatic camera, specifically: TopCon TRC 50 
IX (Topcon, Tokyo, Japan) for 15 funduscopic color images; TopCon TRC NW6S (Topcon, 
Tokyo, Japan) for 36 funduscopic color images; Canon CR-2 (Canon, Tokyo, Japan) for 56 
funduscopic color images. 
Following a well-established procedure,(11) the pixel-to-mm conversion factor was obtained 
by dividing the average vertical optic disc diameter (ODD) over all images, acquired with 
the same camera at the same resolution by the assumed average disc diameter in mi-
crons (1850 μm), The resulting conversion factor (pixels / microns) was 5.43 for the 
3008x2000 TOPCON TRC 50IX images, 7.31 for the 2240x1488 TOPCON TRC 50IX im-
ages, 6.43 for the 3008x2000 TOPCON TRC NW6S, 5.65 for the 5184x3456 Canon CR2 
images and 8.03 for the 2592x3456 Canon CR2 images. 
 
Image analysis 
VAMPIRE measures semi-automatically morphological parameters of the retinal vessels 
in fundus images. Details and validation have been reported elsewhere (5,7,14,21). Measure-
ments (Table 3, supplemental material) include CRAE and CRVE, summarizing the widths 
of the six largest arteries and venules respectively (from the revised formulas of 
Knudtson);(12) AVR = CRAE/CRVE; the FD, a measure of the geometric complexity of the 
vessel network in zone C, is computed as the generalized dimensions D0, D1 and D2, 
which correspond, respectively, to the capacity (or box-counting) dimension, information 
(or Shannon) dimension, and correlation dimension of the vascular network;(13,30) and arte-
rial and venular vascular tortuosity, averaged respectively over the six largest arteries and 
venules.(14)  
Briefly, VAMPIRE starts by locating the optic disc contour and the macula center, enabling 
the definition of the usual retinal coordinates (x axis through OD and macula centers, 
origin in the OD center) and circular zones around the OD (Figure 1): zone A (between 
OD center and 0.5 ODD), zone B (between 0.5 and 1 ODD), and zone C (between 0.5 
and 2 ODD). Efficient manual correction can be performed when the automatic location of 
the optic disc or fovea are found to be incorrect. Vessels are subsequently detected and 
labeled as arterioles or venules automatically, and again corrected manually. AVR, CRAE 
and CRVE are computed in zone B, FD and vascular tortuosity in zone C. Raw measure-
ments of CRAE and CRVE are in pixels. 
 
Statistical analysis 
Categorical data are reported as numbers and percentages and continuous variables as 
mean and standard deviation or median and 25th-75th percentiles, where appropriate. For 
univariate analysis, we compared retinal vascular parameters between NAION cases and 
controls using the Wilcoxon matched-pairs signed-ranks test.  
For subgroup analysis, we examined whether the differences in retinal vascular parame-
ters between NAION cases and controls varied with the NAION stage. For this purpose, 
we performed multivariate linear regression with retinal vascular parameters as dependent 
variable (Yi), as follows: 
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where, for the i-th subject, NAION is a binary variable indicating whether the subject is a 
NAION case (value 1) or control (value 0), Stage is a binary variable coding whether the 
NAION case is enrolled during the acute (value 1) or resolutive (value 0) stage,    is 1 
when the patient is NAION (otherwise 0), and e is the idiosyncratic error term. The β re-
gression coefficients are the estimated effects of a unit change in each independent vari-
able on the retinal vascular parameter. We tested the first-order interaction involving the 
NAION and Stage terms (i.e., γ) for statistical significance. To account for case-control 
matching, we used Generalized Estimated Equations.  
Two-sided p-values <0.05 were considered statistically significant. All analyses were per-
formed using Stata Special Edition version 14.0 (Stata Corporation, College Station, TX, 
USA). 
 
RESULTS  
 
Study sample 
Eighty-two patients were screened and 25 patients were excluded from the study sample 
due to the diagnosis of AAION (n=7), low image resolution (resolution <1080 pixels, n=4), 
rejection by the software (n= 14, due to blur or i inadequate centering). 57 patients were 
included in the analysis after exclusion, of which 35 had acute NAION and 22 were 
evaluated at the time of resolution of the optic nerve edema. The mean delay of resolving 
papillary edema was 45 days. Fifty-seven patients were included in the control group. 
Baseline characteristics for NAION cases and controls are summarized in Table 1. 
 
NAION vs. matched control subjects 
Compared with controls, the median of AVR, arteriolar and venular tortuosity values of 
NAION cases were consistently lower, both in the full analytical sample and within each 
subgroup, with no evidence of significant interaction according to NAION stage (Table 2).  
 
In contrast, the observed differences in median CRAE and CRVE values between NAION 
cases and controls varied with the AION stage ( p for interaction = .001 and .03, 
respectively, Table 2). NAION patients had higher median CRAE and CRVE values than 
controls for acute NAION, but not so at the resolution stage. Yet, the findings from the 
subgroup analysis for CRAE should be interpreted with caution  as the difference between 
NAION cases and controls in the full analytical sample was not significant (P = .41, Table 
2).  
 
Substantial variability was observed in median D0a values among controls, while median 
D0a values (i.e., 1.55, Table 2) were similar for NAION cases across study subgroups 
defined by NAION stage. This was evidenced by the significant first-order interaction in 
subgroup analysis for D0a. This latter observation might reflect random variability or 
confounding by an extraneous factor in D0a values among controls. 
 
DISCUSSION 
 
This study suggests that eyes with NAION differ from controls in having higher CRVE and 
lower AVR and vascular tortuosity. Acute NAION eyes showed increased CRAE and 
CRVE, whereas eyes at the resolution stage exhibited reduced CRAE, similar CRVE and 
increased D0a in comparison with controls.  
To our best knowledge, this is the first study exploring the retinal vessel phenotype from 
fundus images in NAION. Comorbidities associated with NAION, such as age, systemic 
hypertension and diabetes,(15) have been linked with changes in CRAE, CRVE or AVR. At 
this time, retinal vascular changes in OSA are unknown; to consider potential biases, we 
compared NAION patients with control subjects matched for sex, age, systemic hyperten-
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sion, diabetes as well as OSA. We can therefore assume that differences between NAION 
and control groups are related to the occurrence of NAION itself. 
The first important result is the increase in CRVE at the acute stage of NAION. This 
change is no longer detected at resolution stage, suggesting that dilation of veins is pre-
sent at the time of initial damage. The same trend was noted for CRAE. These data are 
consistent with the hypothesis of venous congestion within the anterior optic nerve sug-
gested by Levin et al. (16) and with the concept of compartment syndrome.(17) Further re-
search and larger cohorts are needed to understand these retinal vascular changes, es-
pecially if they are related to vascular changes within the optic nerve or if they only reflect 
temporary changes within the retina without simultaneous vascular changes within the 
optic nerve. Magnetic resonance imaging angiography could be explored to study oph-
thalmic artery and orbital veins, vessels widths, velocity, insufficiency and thrombosis. 
The second relevant result is that tortuosity was significantly lower in the NAION group 
than in the control group, whatever the stage of NAION. Tortuosity (a dimensionless reti-
nal vessel trait) has been previously associated with axial length and spherical 
equivalent,(18) which we took into account when matching patients and controls. Reduced 
arterial tortuosity has been associated with age, elevated blood pressure and higher body 
mass index, all factors controlled by our matching strategy.(18,19) Therefore, lower tortuosity 
seems to be a constant vascular parameter associated with NAION, both at the early and 
resolution stage of the disease. This vascular trait should be further tested as a risk factor 
for N-AION. Retinal tortuosity should also be studied further as a vascular marker of 
changes in the vascular network of the optic nerve.     
We found that fractal dimension (D0a) did not change significantly at different disease 
stages. The FD captures the complexity of the retinal vascular tree as a geometric pattern, 
including the degree of branching complexity.(20) We used a multifractal approach which 
calculates multiple fractal dimensions from ~1,000 randomly chosen starting points on the 
vessel tree. As this measure considers the retinal vascular system as a whole and at dif-
ferent scales, it is accepted as a  quantitative measure of the complexity of the overall 
vascular architecture.(21) Our results show a substantial variability in median D0a values 
among controls, while median D0a values (i.e., 1.55, Table 2) were similar for NAION 
cases across study subgroups defined by NAION stage. Larger cohorts are necessary to 
confirm the variability of the FD.  
Finally, this study does not allow us to conclude whether changes of retinal vascular pa-
rameters precede the occurrence of NAION, nor whether it is an associated phenomenon 
or a consequence of vascular abnormalities in the optic nerve. A longitudinal study is nec-
essary to understand the evolution of the retinal vascular parameters. Once the optic 
nerve edema resolves, some retinal changes seem to disappear, as reported in our trans-
versal study. Our results could, however, suggest that these retinal abnormalities are as-
sociated with the evolution of the disease, since control and NAION groups shares the 
same risk factors susceptible to change retinal vascular parameters.  
We do acknowledge several limitations to our study. First, the size of our cohort of NAION 
patients is modest. Second, the results of case-control study design, even though largely 
used in the literature, may be sensitive to confounding unmeasured factors. Hence some 
of the associations observed in subgroup analysis might be spurious or explained by ran-
dom variability. For this reason, the findings from subgroup analysis for CRAE and D0a 
parameters especially should be interpreted with caution. A longitudinal study is also 
needed in order to better understand the time changes in vascular parameters between 
the acute and resolution stage. Third, CRAE and CRVE cannot identify differences in di-
ameters between peripapillary and distal vessels.(4) Direct measurements of vessel widths 
along vessel segments would be preferable, and can be obtained from VAMPIRE soft-
ware. Fourth, the potential variability of the magnification error due to different cameras 
has to be taken into account; here, its effect was limited by the use of a pixel-micron con-
version factor adjusted to the average optic disc size and the fundus camera. Finally, the 
stability and repeatability of FD measures is the object of ongoing analysis.(31) 
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In conclusion, to our best knowledge, this is the first study of the retinal vessel phenotype 
in patients with non-arteritic anterior ischemic optic neuropathy. This case-control study 
showed that NAION patients exhibited more frequently arteriolar and venular dilations. 
Retinal vascular changes differ from the acute to the resolution stage, which suggests that 
some vascular regulation takes place in the latter. Lower tortuosity and higher FD found in 
NAION patients should be further studied since they could represent a vascular surrogate 
within the retina associated with the occurrence of NAION.  
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FIGURE 
 
Figure 1: Retinal Zones and segmentation using Vampire 
1A: Example of fundus image of one eye with NAION, and segmentation of retinal vein or 
artery vessels.   Zones A, B and C are used in the standard reference system based on 
center and radius of the optic nerve disc (OD), and on the location of the fovea. The sys-
tem divides the image in concentric regions around the OD center. The zones are defined 
as zone A (between OD center and 0.5 ODD), zone B (between 0.5 and 1 ODD), and 
zone C (between 0.5 and 2 ODD). Periphery is defined as the area outside Zone C.  
1B: example of fractal dimension analysis of the same ocular fundus.  
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TABLES:  
 
Table 1: Demographics of patients and control subjects  
Patients were matched for sex, systemic hypertension, OSA and diabetes.  
OSA: obstructive sleep apnea syndrome. 
 
 
Table 2: Difference in retinal vascular parameters between NAION cases and 
controls stratified according AION stage. 
Values for FD were missing for 11 NAION and 13 control patients.  
AVR: Arteriole to venule ratio; CRAE: Central retinal arterial equivalent; CRVE: 
Central retinal venular equivalent; OD: optic disc, ZoneCATort: Average tortuosity 
of the largest arterioles in zone C; ZoneCVTort: Average tortuosity of the largest 
venules in zone C; FD: Fractal dimension; Num1stBa: number of first branching 
points in arterial vessel trees detected in zone C ; Num1stBv: number of first 
branching points in venular vessel trees detected in zone C.  
 
Table 3 (supplemental material): Description of main vascular parameters measured 
using VAMPIRE software. Zone B and C are illustrated in Figure 1.   
 
 
 
 
  
 Characteristics* 
Control 
(n=57) 
NAION 
(N=57) 
Acute stage of 
NAION 
(n=35) 
Resolution 
stage of 
NAION 
(n=22) 
p value 
(NAION 
vs control 
group) 
Female gender, n 
(%) 
25 (44) 25 (44) 13 (37) 12 (55) 
* 
Eye n (%)       0.77 
Right  34 32 20 12 
 Left 23 25 15 10 
 
Age, mean (SD) 
71 (8) 70 (8) 69 (8) 73 (7) * 
Systemic hyperten-
sion  
31 (54%) 31 (54%) 18 (51%) 13 (59%) 
* 
OSA 24 (42%) 24 (42%) 15 (43%) 9 (41%) * 
Diabetes 12 (21%) 12 (21%) 9 (26%) 3 (14%) * 
 
 
Table 1
 Table 2. Difference in retinal vascular parameters between NAION cases and controls stratified according AION stage. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Retinal vascular pa-
rameter 
 NAION cases (1)  Controls (2)  Difference (1 – 2) P 
Stage n Median (IQR)  n Median (IQR)  n Median (IQR)  
CRAE, µm All 57 156 (147;177)  57 160 (150;168)  57 6 (-19;19) .41 
 Acute  35 172 (149;182)  35 161 (155;170)  35 11 (-19;37) 
.03* 
 
Resolution 22 151 (147;157)  22 152 (143;167)  22 -8 (-17;9) 
CRVE, µm All 57 232 (206;256)  57 210 (200;224)  57 16 (-6;47) <.001 
 Acute  35 241 (216;270)  35 210 (200;227)  35 28 (6;65) 
.001* 
 
Resolution 22 209 (196;236)  22 212 (197;221)  22 4 (-13;17) 
AVR All 57 0.71 (0.66;0.76)  57 0.76 (0.71;0.79)  57 -0.03 (-0.14;0.04) .01 
 Acute  35 0.70 (0.66;0.76)  35 0.78 (0.71;0.81)  35 -0.06 (-0.14;0.05) 
.23* 
 
Resolution 22 0.72 (0.68;0.77)  22 0.74 (0.68;0.78)  22 0.00 (-0.05;0.03) 
ZoneCATort, ×10-5 All 57 6.7 (2.5;13.3)  57 27.4 (18.7;53.2)  57 -20.5 (-50.9;-9.3) <.001 
 Acute  35 6.8 (2.6;17.2)  35 30.2 (17.1;79.0)  35 -22.2 (-75.2;-7.2) 
.14*  Resolution 22 5.5 (2.3;11.7)  22 24.5 (18.7;43.0)  22 -19.6 (-36.0;-9.3) 
ZoneCV Tort, ×10-5 All 57 7.2 (3.2;13.1)  57 19.9 (10.2;45.8)  57 -15.2 (-37.2;-1.4) <.001 
 Acute  35 8.3 (3.6;17.3)  35 21.8 (10.3;41.8)  35 -16.7 (-29.6;-0.3) 
.91*  Resolution 22 5.4 (2.8;10.0)  22 16.0 (8.8;54.0)  35 -11.1 (-43.5;-3.2) 
Num1stBA All 57 2 (1;3)  57 2 (1;3)  57 0 (-1;1) .64 
 Acute  35 2 (1;2)  35 2 (1;3)  35 -1 (-2;1) 
.08* 
 Resolution 22 2 (1;3)  22 2 (1;2)  22 1 (-1;1) 
(Continued) 
Table 2
 Table 2 (Continued) 
Retinal vascular pa-
rameter 
 NAION cases (1)  Controls (2)  Difference (1 – 2) P 
Stage n Median (IQR)  n Median (IQR)  n Median (IQR)  
Num1stBV All 57 2 (1;3)  57 2 (2;3)  57 0 (-1;1) .20 
 Acute  35 2 (1;3)  35 2 (2;3)  35 0 (-1;1) 
.32*  Resolution 22 2 (1;3)  22 2 (1;3)  22 -0.5 (-2;1) 
D0a All 46 1.55 (1.51;1.59)  44 1.52 (1.48;1.57)  34 0.04 (-0.02;0.11) .02 
 Acute  29 1.55 (1.50;1.59)  25 1.54 (1.48;1.58)  20 0.01 (-0.05;0.08) 
.04*  Resolution 17 1.55 (1.54;1.59)  19 1.50 (1.46;1.56)  14 0.07 (0.00;0.11) 
D1a All 46 1.54 (1.50;1.58)  44 1.53 (1.49;1.57)  34 0.01 (-0.02;0.06) .33 
 Acute  29 1.54 (1.49;1.58)  25 1.54 (1.49;1.57)  20 -0.01 (-0.09;0.06) 
.19*  Resolution 17 1.54 (1.53;1.58)  19 1.52 (1.47;1.56)  14 0.03 (-0.01;0.07) 
D2a All 46 1.53 (1.50;1.58)  44 1.51 (1.48;1.56)  34 0.01 (-0.04;0.06) .40 
 Acute  29 1.53 (1.48;1.57)  25 1.52 (1.48;1.56)  20 -0.01 (-0.07;0.05) 
.34*  Resolution 17 1.53 (1.51;1.58)  19 1.51 (1.46;1.55)  14 0.02 (-0.01;0.07) 
D0v All 46 1.54 (1.49;1.57)  44 1.51 (1.47;1.55)  34 0.03 (-0.02;0.08) .06 
 Acute  29 1.53 (1.49;1.57)  25 1.52 (1.47;1.56)  20 0.01 (-0.03;0.07) 
.60*  Resolution 17 1.54 (1.51;1.57)  19 1.50 (1.45;1.54)  14 0.05 (-0.01;0.09) 
D1v All 46 1.53 (1.49;1.56)  44 1.51 (1.48;1.56)  34 0.01 (-0.03;0.07) .41 
 Acute  29 1.53 (1.48;1.56)  25 1.52 (1.48;1.56)  20 -0.01 (-0.04;0.06) 
.59*  Resolution 17 1.53 (1.50;1.56)  19 1.51 (1.46;1.55)  14 0.03 (-0.02;0.07) 
D2v All 46 1.52 (1.48;1.56)  44 1.51 (1.47;1.55)  34 0.01 (-0.03;0.07) .42 
 Acute  29 1.52 (1.47;1.56)  25 1.52 (1.47;1.56)  20 -0.01 (-0.04;0.06) 
.57*  Resolution 17 1.53 (1.49;1.56)  19 1.50 (1.45;1.54)  14 0.03 (-0.02;0.07) 
Abbreviations: AVR, arteriole-to-venule ratio; CRAE, central retinal arterial equivalent; CRVE, central retinal venular equivalent; IQR, interquartile range 
(i.e., 25-75
th
 percentiles); NAION, non-arteritic ischemic optic neuropathy; Num1stBa, number of first branching points in arterial vessel trees detected in 
 zone C; Num1stBV, number of first branching points in venular vessel trees detected in zone C; ZoneCATort, average tortuosity of the largest arteriole in 
zone C; ZoneCV Tort, average tortuosity of the largest venule in zone C. 
* P for first-order interaction term involving NAION status and stage. 
Figure 1A
Click here to download high resolution image
Figure 1B
Click here to download high resolution image
This retrospective case series with matched controls showed that non-arteritic anterior 
ischemic optic neuropathy patients exhibited arteriolar and venular dilations at the acute 
stage more frequently than controls. Retinal vascular changes differed between the acute 
and the resolution stage, suggesting that some vascular regulation takes place in the latter. 
In the resolution stage, arterial and venular width values normalized, whereas the fractal 
dimension increased.  
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CRAE  A summative measure of arteriolar width in zone B, based 
on the widths of the six largest arteries (Figure 1, vessels in 
red), and a function of coefficients calculated from the width 
of arteries at bifurcations. 
 
CRVE  A summative measure of venular width in zone B, based on 
the widths of the six largest venules (Figure 1, vessels in 
blue), and a function of coefficients calculated from the width 
of venules at bifurcations. 
 
Fractal dimension  Retinal vasculature is a complex branching structure. Its 
complexity is not easily captured by conventional geometric 
measurements. The fractal dimension (FD) was introduced 
to quantify the complexity of self-similar structures, i.e. 
geometric patterns repeating themselves over multiple 
dimensions, or spatial scales. The dimensionless FD has 
become an accepted measure of the complexity of the 
retinal vascular network (Figure 1). See the main text for 
pointers to the main types of FD and algorithms to compute 
them.   
 
Tortuosity  
 
Tortuosity measures how twisted vessels are. The simple 
arc-to-chord ratio fails to take into account multiple points of 
inflection along a vessel segment. The VAMPIRE software 
adopts the best performing algorithm identified in the 
experimental comparison by Lisowska et al.(14) Tortuosity is 
averaged over the six largest arteries and venules in zone 
C.  
 
 
TABLE 3: Description of main vascular parameters measured using VAMPIRE 
software. Zone B and C are illustrated in Figure 1.   
Supplementary Material:table 3
